Group

Maxim Group Keeps Their Buy Rating on Moleculin Biotech (MBRX)

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Moleculin Biotech (MBRX), with a price target of $3. The company’s shares opened today at $1.27. McCarthy commented: “Following last month’s clearance to begin its European clinical trial of WP1220 (STAT3 inhibitor) in the topical treatment of cutaneous T-cell lymphoma […]

4
Like
Save
The Funny Tinge Group Ltd is a Boon to the SNP

It did not take me long to be proved right about this tweet, as the Funny Tinge Group Ltd was immediately promoted to a seat on BBC Question Time, and are going to be there next week too. The BBC no longer has Westminster’s third party on QT every week, or given much airtime on […]

9
Like
Save